Skip to main content

ReposiTrak Full Year Revenue Increases 11% to $22.6 Million; Net Income Increases 17% to $7.0 Million

Full-Year Earnings Per Share Increases 21%;

Company Ends Fiscal Year with $28.6 Million in Cash and No Debt

ReposiTrak (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today announced financial results for the fourth fiscal quarter and full fiscal year ended June 30, 2025.

Full-Year Fiscal 2025 Financial Highlights:

  • Full-year total revenue increased 11% to $22.6 million from $20.5 million.
  • Recurring revenue represented approximately 99% of total revenue.
  • Full-year operating expense increased 6% to $16.4 million from $15.4 million.
  • Full-year operating income was $6.2 million in fiscal 2025, up 24% from $5.0 million last year.
  • Full-year GAAP net income increased 17% to $7.0 million from $6.0 million last year.
  • Full-year net income to common shareholders was $6.6 million, up 22% from $5.4 million last year.
  • Full-year EPS of $0.36 (basic), or $0.35 (fully diluted), compared to $0.30 (basic) and $0.29 (fully diluted) last year.
  • The Company finished the year with $28.6 million in cash and no bank debt.
  • Cash from operations increased 21% to $8.4 million from $6.9 million last year.
  • During the fiscal year, the Company redeemed 280,372 preferred shares for the stated redemption price of $10.70 per share for a total of $3 million.
  • On September 19, 2025, the board declared a quarterly dividend of $0.02 per quarter ($0.08 per share annually) to shareholders of record on September 30, 2025. The cash dividends will be paid to shareholders of record on or about November 14, 2025. This dividend represents the third 10% increase in ReposiTrak’ s dividend since the dividend was established. Subsequent dividends will be paid within 45 days of each fiscal quarter end.

Fourth Fiscal Quarter Financial Highlights:

  • Fourth quarter total revenue increased 11% to $5.8 million from $5.2 million.
  • Recurring revenue represented approximately 99% of total revenue.
  • Quarterly operating expense increased 8% to $4.2 million from $3.9 million.
  • Quarterly operating income increased 20% to $1.6 million from $1.3 million last year.
  • Quarterly GAAP net income increased 14% to $1.8 million from $1.6 million last year.
  • Quarterly net income to common shareholders was $1.7 million, up 18% from $1.5 million last year.
  • Quarterly EPS of $0.09 compared to $0.08 in the prior year fourth fiscal quarter.
  • During the quarter, the Company redeemed 70,093 preferred shares for the stated redemption price of $10.70 per share for a total of $749,995.

Randall K. Fields, Chairman and CEO of ReposiTrak commented, “We continue to refine our highly successful traceability initiative. Over the past year, we have shifted from a hub-centric model, driven by large retailers, to a supplier-centric model, solving problems for individual suppliers. This approach aligns perfectly with the traceability demands and has increased our engagement with individual suppliers for other solutions, including compliance and supply chain, as well. The success of this supplier-centric approach is opening additional doors with customers large and small, facilitating cross-selling and expanding our addressable market for each of our solutions. The impact of this initiative is evident not only in our continued revenue growth across all business lines, but also in increasing deferred revenue.”

“To support this opportunity, we invested in infrastructure to further expand automation and promote accelerating the customer onboarding,” continued Mr. Fields. “These investments are beginning to pay off, enabling us to meet the substantial demand without expanding headcount, further improving our revenue per employee metric. The result of this initiative will be a far greater number of deals, far greater customer diversification and an even more durable moat around our business along with expansion of the cross-selling opportunities.”

“Our efficient operational model is enabling us to translate 11% topline growth into 24% growth in operating income and 22% growth in net income to common shareholders,” concluded Mr. Fields. “With an already strong balance sheet, supported by more than $28 million in cash, we continue to redeem stock, once again increase our dividend, and return capital to shareholders at an accelerated pace. We have barely scratched the surface of the overall opportunity for our traceability solution and cross selling for compliance and supply chain, and the market continues to expand before our eyes. We maintain our goal of average annualized revenue growth of 10-20%, and significantly greater growth in profitability.”

Fourth Fiscal Quarter Financial Results (three months ended June 30, 2025, vs. three months ended June 30, 2024):

Total revenue was up 11% to $5.8 million as compared to $5.2 million in the prior-year fourth quarter. Total operating expense was $4.2 million, up 8% compared to $3.9 million last year. SG&A expense was $2.9 million, up 7% from $2.7 million last year. GAAP net income was $1.8 million compared to $1.6 million. Net income to common shareholders was $1.7 million, or $0.09 per diluted share, compared to $1.5 million, or $0.08 per diluted share, an increase of 18%.

Year-to-Date Financial Results (12 months ended June 30, 2025, vs. 12 months ended June 30, 2024):

Total revenue was up 11% to $22.6 million as compared to $20.5 million in the prior-year period. Total operating expense was $16.4 million, up 6% compared to $15.4 million last year. GAAP net income was $7.0 million compared to $6.0 million. Net income to common shareholders was $6.6 million, or $0.36 per basic and $0.35 per diluted share, compared to $5.4 million, or $0.30 per basic and $0.29 per diluted share last year.

Return of Capital:

In the fourth quarter of fiscal 2025, the Company redeemed 70,093 preferred shares at the stated redemption price of $10.70 per share for a total of $749,995. Since inception, the Company has redeemed 501,679 shares of preferred stock for a total of $5.4 million. The amount remaining to redeem the preferred shares is $3.6 million. At the current rate of redemption, the Company anticipates redeeming all of its preferred shares issued and outstanding on or before December of 2026.

During fiscal 2025, the Company repurchased 8,681 common shares for a total of $200,033 or an average of $23.13 per share. The Company has approximately $8 million remaining of the $21 million total common share buyback authorization.

In September 2022, the Company’s Board of Directors declared a quarterly cash dividend of $0.015 per share ($0.06 per year). In November 2023, the Board approved a 10% increase in the quarterly cash dividend, to $0.066 cents per share annually, or $0.0165 cents per share quarterly, commencing with the December 2023 dividend. On June 20, 2025, the Board declared a quarterly dividend of $0.01815 per quarter ($0.0726 per share annually) to shareholders of record on June 30, 2025. Beginning with the quarterly cash dividend payable on or about November 14, 2025 to shareholders of record as of September 30, 2025, shareholders will receive a 10% increase in the quarterly cash dividend, or a dividend of $0.02 per quarter ($0.08 annually). This represents the third increase in the Company’s dividend since the dividend was established. Subsequent dividends will be paid within 45 days of each fiscal quarter end.

Balance Sheet:

The Company had $28.6 million in cash and cash equivalents at June 30, 2025, compared to $25.2 million at June 30, 2024. As of June 30, 2025, the Company had no bank debt.

Conference Call:

The Company will host a conference call at 4:15 p.m. Eastern today to discuss the Company’s results. The conference call will also be webcast and will be available via the investor relations section of the Company’s website, www.parkcitygroup.com.

Participant Dial-In Numbers:

Date: Monday, September 29, 2025

Time: 4:15 p.m. ET (1:15 p.m. PT)

Toll-Free: 1-877-407-9716

Toll/International 1-201-493-6779

Conference ID: 13755695

Replay Dial-In Numbers:

Toll Free: 1-844-512-2921

Toll/International: 1-412-317-6671

Conference ID: 13755695

Replay Start: Monday, September 29, 2025, 7:15 p.m. ET

Replay Expiry: Wednesday, October 29, 2025, at 11:59 PM ET

About ReposiTrak

ReposiTrak (NYSE: TRAK), formerly Park City Group, provides retailers, suppliers and wholesalers with a robust solution suite to help reduce risk and remain in compliance with regulatory requirements, enhance operational controls and increase sales with unrivaled brand protection. Consisting of three product families – food traceability, compliance and risk management and supply chain solutions – the Company’s integrated, cloud-based applications are supported by an unparalleled team of experts. For more information, visit https://repositrak.com

Forward-Looking Statement

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “if”, “should” and “will” and similar expressions as they relate to ReposiTrak Inc., Park City Group d/b/a ReposiTrak, or Park City Group, Inc. (“ReposiTrak”) are intended to identify such forward-looking statements. ReposiTrak may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see “Risk Factors” in ReposiTrak annual report on Form 10-K, its quarterly report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

REPOSITRAK, INC.

Consolidated Balance Sheets

 

 

June 30,

June 30,

 

2025

2024

Assets

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash

$

28,568,805

 

$

25,153,862

 

Receivables, net of allowance for doubtful accounts of $242,437 and $227,573 at June 30, 2025 and 2024, respectively

 

4,133,026

 

 

3,678,627

 

Contract asset – unbilled current portion

 

428,585

 

 

181,680

 

Prepaid expense and other current assets

 

555,384

 

 

285,998

 

Total Current Assets

 

33,685,800

 

 

29,300,167

 

 

 

 

 

 

 

 

Property and equipment, net

 

602,172

 

 

513,277

 

 

 

 

 

 

 

 

Other Assets:

 

 

 

 

 

 

Deposits and other assets

 

22,414

 

 

22,414

 

Prepaid expense – less current portion

 

6,568

 

 

2,609

 

Contract asset – unbilled long-term portion

 

-

 

 

108,052

 

Operating lease – right-of-use asset

 

-

 

 

250,306

 

Customer relationships

 

-

 

 

131,400

 

Goodwill

 

20,883,886

 

 

20,883,886

 

Capitalized software costs, net

 

128,207

 

 

384,621

 

Total Other Assets

 

21,041,075

 

 

21,783,288

 

 

 

 

 

 

 

 

Total Assets

$

55,329,047

 

$

51,596,732

 

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable

$

282,146

 

$

265,086

 

Accrued liabilities

 

1,841,839

 

 

1,554,775

 

Contract liability – deferred revenue

 

3,175,908

 

 

2,441,234

 

Operating lease liability – current

 

-

 

 

64,076

 

Notes payable and financing leases – current

 

231,225

 

 

217,971

 

Total current liabilities

 

5,531,118

 

 

4,543,142

 

 

 

 

 

 

 

 

Long-term liabilities

 

 

 

 

 

 

Operating lease liability – less current portion

 

-

 

 

198,972

 

Notes payable and financing leases – less current portion

 

278,748

 

 

-

 

Total liabilities

 

5,809,866

 

 

4,742,114

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Preferred Stock; $0.01 par value, 30,000,000 shares authorized;

 

 

 

 

 

 

Series B Preferred, 700,000 shares authorized; 336,098 and 616,470 shares issued and outstanding at June 30, 2025 and 2024 respectively

 

3,361

 

 

6,165

 

Common Stock, $0.01 par value, 50,000,000 shares authorized; 18,282,805 and 18,234,893 issued and outstanding at June 30, 2025 and 2024, respectively

 

182,830

 

 

182,351

 

Additional paid-in capital

 

62,181,156

 

 

64,655,902

 

Accumulated other comprehensive loss

 

(11,256

)

 

(27,390

)

Accumulated deficit

 

(12,836,910

)

 

(17,962,410

)

Total stockholders’ equity

 

49,519,181

 

 

46,854,618

 

Total liabilities and stockholders’ equity

$

55,329,047

 

$

51,596,732

 

REPOSITRAK, INC.

Consolidated Statements of Operations

 

 

For the Years Ended

 

June 30,

 

2025

2024

 

 

 

 

 

 

 

Revenue

$

22,606,066

 

$

20,453,320

 

 

 

 

 

 

 

 

Operating expense:

 

 

 

 

 

 

Cost of revenue and product support

 

3,681,330

 

 

3,416,450

 

Sales and marketing

 

5,843,272

 

 

5,492,719

 

General and administrative

 

5,602,807

 

 

5,330,437

 

Depreciation and amortization

 

1,251,514

 

 

1,189,483

 

Total operating expense

 

16,378,923

 

 

15,429,089

 

 

 

 

 

 

 

 

Income from operations

 

6,227,143

 

 

5,024,231

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

Interest income

 

1,383,535

 

 

1,272,719

 

Interest expense

 

(48,671

)

 

(28,166

)

Gain on lease termination

 

12,262

 

 

-

 

Realized gain on short term investments

 

97,384

 

 

-

 

Unrealized gain (loss) on short term investments

 

(17,676

)

 

63,997

 

Income before income taxes

 

7,653,977

 

 

6,332,781

 

 

 

 

 

 

 

 

(Provision) for income taxes

 

(675,850

)

 

(374,491

)

Net income

 

6,978,127

 

 

5,958,290

 

 

 

 

 

 

 

 

Dividends on Preferred Stock

 

(360,306

)

 

(549,645

)

 

 

 

 

 

 

 

Net income applicable to common shareholders

$

6,617,821

 

$

5,408,645

 

 

 

 

 

 

 

 

Weighted average shares, basic

 

18,262,000

 

 

18,202,000

 

Weighted average shares, diluted

 

19,141,000

 

 

18,931,000

 

Basic earnings per share

$

0.36

 

$

0.30

 

Diluted earnings per share

$

0.35

 

$

0.29

 

 

 

 

 

 

 

 

Comprehensive income:

 

 

 

 

 

 

Net income

$

6,978,127

 

$

5,958,290

 

Other comprehensive loss:

 

 

 

 

 

 

Unrealized gain (loss) on available-for-sale securities

 

16,134

 

 

(27,390

)

Total comprehensive income

$

6,994,261

 

$

5,930,900

 

REPOSITRAK, INC.

Consolidated Statements of Cash Flows

 

 

For the Years Ended

 

June 30,

 

2025

2024

Cash flows from operating activities:

 

 

 

 

 

 

Net income

$

6,978,127

 

$

5,958,290

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

1,251,514

 

 

1,189,483

 

Amortization of operating right of use asset

 

63,597

 

 

60,490

 

Stock compensation expense

 

403,783

 

 

367,147

 

Gain on termination of operating lease

 

(12,262

)

 

-

 

Bad debt expense

 

600,000

 

 

375,000

 

(Increase) decrease in:

 

 

 

 

 

 

Accounts receivables

 

(1,301,304

)

 

(1,525,329

)

Operating right of use asset

 

186,709

 

 

-

 

Long-term receivables, prepaids and other assets

 

(447,479

)

 

123,355

 

Increase (decrease) in:

 

 

 

 

 

 

Accounts payable

 

17,060

 

 

(166,301

)

Operating lease liability

 

(250,786

)

 

(58,770

)

Accrued liabilities

 

196,499

 

 

102,803

 

Deferred revenue

 

734,674

 

 

538,233

 

Net cash provided by operating activities

 

8,420,132

 

 

6,964,401

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

Purchase of property and equipment

 

(15,965

)

 

(73,317

)

Sale (purchase) of marketable securities

 

16,134

 

 

(27,390

)

Net cash (used in) provided by investing activities

 

169

 

 

(100,707

)

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

Common stock buyback/retirement

 

(200,035

)

 

(1,515,574

)

Redemption of Series B-1 preferred

 

(2,999,970

)

 

(2,367,996

)

Proceeds from exercise of warrants

 

79,120

 

 

-

 

Proceeds from employee stock plan

 

134,346

 

 

111,839

 

Dividends paid

 

(1,656,377

)

 

(1,721,657

)

Payments on notes payable and capital leases

 

(362,442

)

 

(207,323

)

Net cash used in financing activities

 

(5,005,358

)

 

(5,700,711

)

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents

 

3,414,943

 

 

1,162,983

 

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

25,153,862

 

 

23,990,879

 

Cash and cash equivalents at end of period

$

28,568,805

 

$

25,153,862

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

 

Cash paid for income taxes

$

435,059

 

$

332,222

 

Cash paid for interest

$

21,023

 

$

15,223

 

Cash paid for operating leases

$

56,244

 

$

73,291

 

 

 

 

 

 

 

 

Supplemental Disclosure of Non-Cash Investing and Financing Activities

 

 

 

 

 

 

Common Stock to pay accrued liabilities

$

313,218

 

$

536,879

 

Dividends accrued on Preferred Stock

$

360,306

 

$

549,645

 

Right of use asset

$

654,444

 

$

-

 

 

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.